Head to Head Comparison: Sientra (NASDAQ:SIEN) versus Demant A/S (OTCMKTS:WILLF)

Demant A/S (OTCMKTS:WILLF) and Sientra (NASDAQ:SIEN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and earnings.

Analyst Recommendations

This is a summary of recent ratings for Demant A/S and Sientra, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Demant A/S	0	0	0	0	N/A
Sientra	0	1	1	0	2.50

Sientra has a consensus target price of $7.50, suggesting a potential upside of ∞. Given Sientra’s higher probable upside, analysts clearly believe Sientra is more favorable than Demant A/S.

Earnings and Valuation

This table compares Demant A/S and Sientra’s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Demant A/S	N/A	N/A	N/A	$23.08	2.19
Sientra	$90.55 million	0.00	-$73.31 million	($5.57)	N/A

Demant A/S has higher earnings, but lower revenue than Sientra. Sientra is trading at a lower price-to-earnings ratio than Demant A/S, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

13.6% of Demant A/S shares are owned by institutional investors. Comparatively, 15.4% of Sientra shares are owned by institutional investors. 1.5% of Sientra shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Demant A/S and Sientra’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Demant A/S	N/A	N/A	N/A
Sientra	-65.93%	N/A	-40.45%

Summary

Sientra beats Demant A/S on 5 of the 9 factors compared between the two stocks.

About Demant A/S

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

About Sientra

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.